Curasight

Curasight is focused on developing novel and innovative PET imaging ligands for prostate cancer.

HQ location

Copenhagen, Denmark

Website

Launch date

Jan 2013

Employees

Market cap

Enterprise value

$30m

Share price

DKK4.18 CURAS.CO

Company register number

35249389

Recent deals

TRT Innovations

https://twitter.com/si4ja https://www.linkedin.com/company/curasight/

Authorizing premium user...